Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketofol versus sevoflurane in emergence agitation after pediatric strabismus surgery
TCTR20240511001Phase 3Completed
- Sponsor
- Queen Sirikit National Institute of Child Health
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketofol and sevoflurane in strabismus (2 arms), sponsored by Queen Sirikit National Institute of Child Health. Primary endpoint: Incidence of emergence agitation. Started Jul 2023; status: completed.
02
Drugs
ketofolsevoflurane
03
Conditions
strabismus
Beyond the preview
Go deeper on TCTR20240511001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240511001.